Research Disclaimer: This article is intended for educational and informational purposes regarding the chemical and biochemical properties of research compounds. All information is provided strictly in a scientific context. This content does not constitute medical advice, nor does it promote the use of any compound for human or veterinary application. All compounds referenced are for laboratory research use only.
TB-500 is the commonly used research designation for a synthetic analogue of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino acid peptide found in virtually all nucleated mammalian cells. First isolated from thymic tissue, Thymosin Beta-4 has been the subject of extensive scientific investigation due to its involvement in actin dynamics, cell migration, and tissue remodelling processes. TB-500 is used in research settings as a representative analogue to study these biological mechanisms under controlled laboratory conditions.
Discovery and Scientific Background
The thymosins were first characterised in the 1960s and 1970s during research into thymic hormones and their role in immune system development. Thymosin Beta-4 was isolated and sequenced as part of this broader programme, with its structural characterisation revealing a highly conserved peptide sequence across mammalian species — an observation that suggested important functional roles.
Early research focused on Thymosin Beta-4’s role in T-cell development and immune modulation. However, subsequent investigations revealed that its expression was not limited to immune cells. Studies identified Tβ4 as a ubiquitous intracellular peptide with particularly high concentrations in platelets, macrophages, and a variety of tissue types, leading researchers to expand their investigations into its roles in cytoskeletal organisation and tissue responses.
TB-500, as a synthetic analogue, has been developed to allow researchers to study the biological activities associated with Thymosin Beta-4 in reproducible experimental systems, without the variability associated with natural tissue-derived extracts.
Molecular Structure and Chemical Profile
| Specification | Data |
| Common Name | TB-500 |
| Full Name | Thymosin Beta-4 (Synthetic Analogue) |
| CAS Number | 77591-33-4 |
| Molecular Formula | C212H350N56O78S |
| Molecular Weight | ~4963.5 g/mol |
| Amino Acid Length | 43 amino acids |
| Appearance | White lyophilized powder |
| Solubility | Soluble in sterile water or bacteriostatic water |
| Storage (Lyophilized) | -20°C, stable up to 24 months |
| Storage (Reconstituted) | +4°C, use within 4 weeks |
| Purity (Research Grade) | >99% by HPLC |
Actin Sequestration and Cytoskeletal Research
The most extensively studied biochemical property of Thymosin Beta-4 is its role as a G-actin sequestering peptide. Actin exists in cells in two forms: globular (G-actin) monomers and filamentous (F-actin) polymers. The dynamic equilibrium between these two forms is central to numerous cellular processes, including cell motility, division, and morphological changes.
Thymosin Beta-4 contains an actin-binding domain — specifically a well-characterised LKKTET motif — through which it binds G-actin monomers, regulating the available pool of actin available for polymerisation. By controlling the ratio of G-actin to F-actin, Thymosin Beta-4 plays a modulatory role in the kinetics of actin filament assembly and disassembly.
This property has made TB-500 a valuable research tool in cell biology investigations focused on cytoskeletal dynamics, particularly in studies examining how cells reorganise their internal architecture in response to external signals or mechanical stimuli.
Cell Migration Research
Research utilising Thymosin Beta-4 and its analogues has explored their potential effects on cell migration in vitro. Studies using scratch assay and transwell migration models have reported enhanced migration of various cell types in the presence of Tβ4, including endothelial cells, keratinocytes, and cardiac progenitor cells.
The proposed mechanism involves Tβ4’s regulation of actin dynamics enabling more efficient cellular movement, potentially through promotion of lamellipodia formation and directional motility. These findings have generated interest in the compound as a research model for studying the cellular mechanics of tissue remodelling and wound response.
Angiogenesis Research
A significant area of Thymosin Beta-4 research has examined its potential influence on angiogenesis — the formation of new blood vessels from existing vasculature. In vitro studies using endothelial cell cultures and ex vivo vascular tissue preparations have reported that Tβ4 can stimulate endothelial cell proliferation, migration, and tube formation under controlled experimental conditions.
Research has suggested that Tβ4 may interact with vascular endothelial growth factor (VEGF) signalling pathways, though the precise molecular mechanisms remain an active area of investigation. These properties have made TB-500 a frequently used research compound in angiogenesis model systems.
Cardiac Research
A distinct body of research has investigated Thymosin Beta-4’s potential role in cardiac tissue biology. Studies in animal models have examined whether Tβ4 can influence the survival and differentiation of cardiac progenitor cells following ischaemic events, with some studies reporting protective effects on cardiac myocytes in vitro under simulated ischaemic conditions.
The mechanism proposed in this research context involves Tβ4’s activation of the PI3K/Akt survival signalling pathway and its potential role in promoting cardiomyocyte survival. This area of research remains early-stage and preclinical in nature.
Laboratory Handling
| Specification | Data |
| Reconstitution Solvent | Bacteriostatic water (preferred) or sterile water |
| Reconstitution Method | Slow injection of solvent along vial wall |
| Lyophilized Storage | -20°C in sealed vial, away from light |
| Reconstituted Storage | +4°C (refrigerator), use within 4 weeks |
| Freeze-Thaw Cycles | Avoid; aliquot before freezing if repeated use planned |
| Handling Notes | Allow to reach room temperature before reconstitution |
Distinction from BPC-157
TB-500 and BPC-157 are frequently discussed together in research contexts, as both are peptides studied for their potential effects on tissue biology. However, they are structurally distinct compounds with different origins, mechanisms, and research profiles. TB-500 is derived from the endogenous Thymosin Beta-4 sequence and acts primarily through actin-binding mechanisms and cell signalling pathways. BPC-157 is a synthetic pentadecapeptide derived from a gastric protein sequence, with a different receptor interaction profile.
In research settings, the two are sometimes studied in combination as complementary tools for investigating tissue response mechanisms, though they should be considered as independent research compounds with distinct scientific characterisations.
Note: TB-500 is available from Aminopept for laboratory and in-vitro research use only. It is not approved for any therapeutic or human use application.
——————————————————————————————————-
TB-500 is available in research-grade, lyophilized form from the Aminopept research catalogue. Supplied for laboratory and in-vitro research use only.
→ View TB-500 in the research catalogue
Leave a Reply